Findings that should speed the development of drugs for Parkinson... (more likely or less likely that a neurot...)

Findings that should speed the development of drugs for Parkinson's disease

Date:11/18/2009

more likely or less likely that a neurotransmitter will be released, but it can't guarantee release. For example, it becomes more likely that a neurotransmitter will be released in a nerve pathway that is used a lot."

Neurotransmitters are small molecules that are released from one nerve cell and which act on the next nerve cell. Some are excitatory, some inhibitory, some modulatory. Dopamine is a modulator. In other words, it smooths out the ups and downs of a nerve cell, effectively telling it 'not to get over excited', or 'not to get over inhibited'. All the inputs add up, and if a nerve cell gets enough plusses, it fires an impulse.

According to Vissel, we are still in the dark ages in understanding the sub-microscopic events that take place in the brain. "We have roughly 100 billion nerve cells in our brains, with up to 100,000 connections each. We're only just beginning to understand that every connection is regulated in the most extraordinarily sophisticated way," he explained.

"The surprising thing is that out of all this irregularity and complexity comes predictable or reliable function. Most of us can catch a ball that is thrown to us without dropping it, for example. When you think about the millions of nerve cell events in that simple act alone, it's remarkable. Unfortunately, in Parkinson's disease this phenomenal ability to regulate movement is lost".

"Our work involved developing sophisticated statistical analysis protocols and mathematical models of synapses, and it helps de-mystify the part of the process that takes place at the dopamine nerve cell synapse. We believe it will help us work out how drugs currently being used to treat Parkinson's Disease are regulating dopamine release. It will also open up new avenues for pharmaceutical development."

'/>"/>

Contact: Alison Heather
a.heather@garvan.org.au
61-292-958-128
Research Australia
Source:Eurekalert

0

GOOD

Page: 1 2
Related medicine news :

1. Shire Reports Findings From an Analysis Examining Emotional Lability in Children With ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII
2. Findings from New Study on Occupational Exposure to BPA of Limited Relevance to Consumers
3. Research Findings Key for Understanding, Interpreting Genetic Testing for Long QT Syndrome
4. Contour Products Promotes Survey for National Respiratory Care Week, Findings Prove Benefits of Contour CPAP Pillow for Sleep Apnea Patients
5. New findings on the formation of body pigment
6. Findings about veracity of peripheral vision could lead to better robotic eyes
7. Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings
8. New findings about brain proteins suggest possible way to fight Alzheimers
9. Corn Refiners Association Comments on Findings in Recent Report on Sugars and High Blood Pressure
10. World Heart Day resonates with recent experts findings on CVD and EU institutions determination to promote heart health
11. Louisiana's TCA Cellular Therapy's Findings Reported at World Stem Cell Summit -- Patients' Legs Saved from Amputation Using Adult Stem Cells

Post Your Comments:

(Date:3/18/2010)... Taxes, Other Tobacco Prevention Initiatives , ... , , ... ... ... WASHINGTON , March 18 Kids in New Jersey will take center stage in the fight against tobacco on March ...

(Date:3/18/2010)... ... , , ... ... ... New Hampshire will take center stage in the fight against tobacco on March 24 as they join thousands of young people nationwide ...

(Date:3/18/2010)... President and CEO, Legacy(SM) , ... , , ... ... WASHINGTON , March ... ...

(Date:3/18/2010)... of U.S. medical students choosing internal medicine residencies ... significantly impact the shortage of primary care physicians. ... Program report, 2,722 U.S. seniors at medical schools ... 3.4 percent increase from 2,632 in 2009. The ... (2,660), 2007 (2,680), and 2006 (2,668). In comparison, ...

(Date:3/18/2010)... In its 21-year history, under the ... leaders, SRLA has trained more than 40,000 teenagers from ... area to complete the 26.2 mile Los Angeles Marathon. ... volunteer leaders will again participate in the LA Marathon. ... SRLA,s mission is to challenge at-risk secondary students to ...

Breaking Medicine News(10 mins):Health News:New Jersey Kids 'Kick Butts' on March 24 2 Health News:New Jersey Kids 'Kick Butts' on March 24 3 Health News:New Jersey Kids 'Kick Butts' on March 24 4 Health News:New Jersey Kids 'Kick Butts' on March 24 5 Health News:New Hampshire Kids 'Kick Butts' on March 24 2 Health News:New Hampshire Kids 'Kick Butts' on March 24 3 Health News:New Hampshire Kids 'Kick Butts' on March 24 4 Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 2 Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 3 Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 4 Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 5 Health News:Residency match results not encouraging for adults needing primary care 2 Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 2 Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 3

[0] New Jersey Kids 'Kick Butts' on March 24 [0] New Hampshire Kids 'Kick Butts' on March 24 [0] Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco [0] Residency match results not encouraging for adults needing primary care [0] Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years

... Inc.,(Nasdaq: ORCH ), a leading worldwide provider ... quarter 2008 financial results on,Thursday, July 31, 2008 ... a,conference call and webcast to discuss the results ... will discuss financial results for the second quarter,2008 ...

... Users to Create a Book on CaringBridge Sites Documenting ... Their Journey Through Treatment or ... nonprofit Web,service that connects families and friends when someone ... provides users with the,ability to preserve their personal Web ...

... MONROVIA, Calif., July 24 STAAR Surgical,Company ... manufacturer and marketer of,minimally invasive ophthalmic products, ... Medicaid Services (CMS) has designated two of ... Intraocular Lenses (NTIOLs). The,lenses are the Afinity ...

... Ore., and CLEVELAND, July 24 Clear Catheter,Systems ... device company developing a proprietary medical catheter clearance,platform, ... round. The,financing was led by X Gen Ltd, ... also includes a grant from the Cleveland Clinic ...

... High Weather Cancellations and Higher Operating Costs to Affect ... ... Thursday, August 7, 2008, DENVER, July 24 Air Methods ... the,world, provided an update on second quarter 2008 results., Based ...

... NEW YORK, July 24 MS -- Today, ... For those who care for their,bodies, by following ... is possible to feel and look younger without ... Mehmet Oz, a cardiothoracic surgeon, author, and frequent ...

Other Medicine News:Health News:Orchid Cellmark To Announce Second Quarter 2008 Financial Results on July 31, 2008 2 Health News:CaringBridge(R) Enhances Web Service by Adding Printable CaringBook Option 2 Health News:CaringBridge(R) Enhances Web Service by Adding Printable CaringBook Option 3 Health News:STAAR Surgical's Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification 2 Health News:STAAR Surgical's Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification 3 Health News:STAAR Surgical's Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification 4 Health News:Clear Catheter Systems Completes $600-Million Financing, Opens Cleveland Office 2 Health News:Air Methods Provides 2nd Quarter Update and Date of Quarterly Conference Call 2 Health News:Air Methods Provides 2nd Quarter Update and Date of Quarterly Conference Call 3 Health News:Air Methods Provides 2nd Quarter Update and Date of Quarterly Conference Call 4 Health News:Live to 100 ... And Feel Great 2

Orchid Cellmark To Announce Second Quarter 2008 Financial Results on July 31, 2008 CaringBridge(R) Enhances Web Service by Adding Printable CaringBook Option STAAR Surgical's Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification Clear Catheter Systems Completes $600-Million Financing, Opens Cleveland Office Air Methods Provides 2nd Quarter Update and Date of Quarterly Conference Call Live to 100 ... And Feel Great

(Date:3/18/2010)... March 18 Poniard Pharmaceuticals, Inc. ... innovative oncology therapies, today announced that the U.S. Patent ... the composition of matter patent for picoplatin as RE41209, ... 2010 . The reissue was applied for May ... , the USPTO released the "Issue Notification" for the ...

(Date:3/18/2010)... , March 18 ... Chief Executive Officer, Pfizer, was elected board ... of America (PhRMA) today at the trade ... Chief Executive Officer Christopher Viehbacher ... Directors, and John C. Lechleiter , ...

(Date:3/18/2010)... results in too much ammonia in the blood. , ... , , ... ... (Logo: ... ...

Breaking Medicine Technology:U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 2 U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 3 U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 4 U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 5 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 2 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 3 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 4 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 5 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 6 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 7 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 8 FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 2 FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 3 FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 4 FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 5 Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 1 Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 2 Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 3 Exposure to lead tobacco smoke raises risk of ADHD 10856 1 Exposure to lead tobacco smoke raises risk of ADHD 10856 2 Measuring and modeling blood flow in malaria 61892 1 Measuring and modeling blood flow in malaria 61892 2

[0] U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter [0] Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts [0] FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels

... Development Pathway, SOUTH SAN FRANCISCO, Calif., Oct. 10 ... it will conduct two Phase 3,clinical trials for the ... planned in total knee replacement surgeries -- and the ... label of management of,post-surgical pain associated with orthopedic surgeries. ...

... Vical Incorporated,(Nasdaq: VICL ) today announced ... potential of its patented Vaxfectin(TM) adjuvant to be ... pandemic influenza vaccine,currently stockpiled by the U.S. government. ... supplies to protect the greatest,number of people in ...

Other Medicine Technology:Anesiva Defines Regulatory Pathway for Adlea with FDA 2 Anesiva Defines Regulatory Pathway for Adlea with FDA 3 Anesiva Defines Regulatory Pathway for Adlea with FDA 4 Anesiva Defines Regulatory Pathway for Adlea with FDA 5 Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant 2 Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant 3 Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant 4

Anesiva Defines Regulatory Pathway for Adlea with FDA Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant

Sterile Straight Packed TOUCH-TROL Suction Catheters...

... are available in two tip ... tip with staggered eyes, and ... types of catheter valve options, ... fingertip control with virtually no ...

Sterile Single Loop Pediatric Suction Catheters with TOUCH-TROL Valve...

... suction catheter design was created to ... while still providing high suctioning efficiency. ... 8 or 10 Fr) feature depth ... placement. Our complete catheter line is ...

Medicine Products:

Sterile Straight Packed Pediatric TOUCH-TROL Suction Catheters Sterile Straight Packed Suction Catheters with SAFE-T-VAC Valve Sterile Single Loop Suction Catheters with TOUCH-TROL Valve AirLife™ Brand Tri-Flo® Single Catheters

Findings that should speed the development of drugs for Parkinson...(more likely or less likely that a neurot...),Health